Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
tissue for in vitro analysis of drug metabolic conversions More
A series of substituted 3,6-diphenyl-7H-[1,2,4] triazolo[3,4-b] [1,3,4] thiadiazines that act as inhibitors of PDE4 More
Related Reports
Market Research Reports provided by reports.iptechex.com
Jan 2008 - 148 pages - $1,740
Dec 2010 - 30 pages - $500
Dec 2010 - 41 pages - $500
Mar 2011 - 41 pages - $500
Dec 2010 - 40 pages - $500
Mar 2011 - 40 pages - $500
Nov 2010 - 933 pages - $1,495
Nov 2010 - 324 pages - $1,495
Dec 2008 - 35 pages - $200
Nov 2011 - 7 pages - $3,835
Your selection
Browse By
- Therapeutic target
- Appendicitis
- Cholangitis, sclerosing
- Colitis
- Colitis, ulcerative
- Constipation
- Crohn's disease
- Diarrhea
- Dyspepsia
- Electrolyte replacement
- Emesis
- Emesis, motion
- Esophagitis
- Flatulence
- Food poisoning
- Gastritis
- Gastroesophageal reflux disorder
- Gastrointestinal (other)
- Gastrointestinal secretions
- Gastroprokinetic
- Helicobacter pylori
- Inflammatory bowel disease
- Irritable bowel syndrome
- Nausea
- Pancreatitis
- Ulcer
- Ulcer, gastric
- Ulcer, gastroduodenal
- Ulcer, peptic
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us